Diabetes

Glyxambi 25/5® Empaglifozin and Linagliptin Tablets
Empaglifozin 25mg + Linagliptin 5mg
- Composition
- Empaglifozin 25mg + Linagliptin 5mg
- Dosage form
- Tablet
- Pack size
- Strip of 10 Tablet
- Manufacturer
- Boehringer Ingelheim
- Also known as
- Steglujan, Qtern, Suglat Plus, Zynquista
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Glyxambi 25/5 mg is a combination of empagliflozin 25 mg and linagliptin 5 mg. A prescription taken by mouth, used with diet and exercise to help adults with type 2 diabetes manage their blood sugar.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Diabetes
Diabetes
Diabetes
Diabetes
